Literature DB >> 29331846

Functional neuroimaging in Rasmussen syndrome.

Ichiro Kuki1, Kazumi Matsuda2, Yuko Kubota3, Tetsuhiro Fukuyama2, Yukitoshi Takahashi2, Yushi Inoue2, Haruo Shintaku4.   

Abstract

PURPOSE: For a diagnosis of Rasmussen syndrome (RS), clinical course together with electroencephalography (EEG) and magnetic resonance imaging (MRI) findings are considered important, but there are few reports on functional neuroimaging. This study investigated cerebral blood flow (CBF)-single photon emission computed tomography (SPECT), central benzodiazepine receptor (BZR)-SPECT, and fluorine-18 fluorodeoxy glucose-positron emission tomography (FDG-PET) in RS patients, and correlated neuroimaging results with MRI and pathological findings.
METHODS: Twenty-three patients diagnosed with RS according to Bien's (2005) diagnostic criteria (including 12 patients with a histological diagnosis) were studied. CBF-SPECT, BZR-SPECT and FDG-PET images were visually evaluated, and the findings correlated with MRI and histological findings.
RESULTS: Hypoperfusion areas were observed in 16 of 22 patients by interictal CBF-SPECT. Hyperperfusion areas were observed in 10 of 12 patients by ictal CBF-SPECT, which correlated with ictal onset area by ictal EEG (IOAE). In the limited data of BZR-SPECT in nine patients, lowered uptake was detected in all nine patients, including two with no MRI abnormalities. Lowered glucose metabolism was observed in affected areas in all five patients by FDG-PET. Histological examination revealed findings of chronic encephalitis in all 12 patients examined, concomitant with focal cortical dysplasia in five patients.
CONCLUSION: In RS patients, functional neuroimaging reveals clear abnormal findings, even before the appearance of MRI abnormalities. BZR-SPECT and FDG-PET could detect the IOAE efficiently even in the absence of MRI abnormalities, while interictal CBF-SPECT occasionally failed to detect IOAE if MRI was normal. Based on BZR-SPECT, refractory epileptic seizures in RS may suggest possible impairment of inhibitory neurons.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Benzodiazepine receptor; Encephalitis; Epilepsy; Focal cortical dysplasia; Positron emission tomography

Mesh:

Substances:

Year:  2018        PMID: 29331846     DOI: 10.1016/j.eplepsyres.2018.01.001

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  1 in total

1.  Adult-onset Rasmussen's Syndrome with associated cortical dysplasia.

Authors:  C Ákos Szabó; Rachel Garvin; Shaheryar Hafeez; Ali Seifi; Linda Leary; Ratna Bhavaraju-Sanka; James M Henry; Alex M Papanastassiou
Journal:  Epilepsy Behav Case Rep       Date:  2018-11-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.